Komtur Pharmaceuticals is one of the world's leading providers of integrated procurement services for pharmaceutical products. Our core fields of expertise are clinical trial supplies and clinical distribution, international pre-marketing, special distribution and individual imports to patients, including narcotics.
As a comprehensive service provider for clinical trials, we offer international procurement services for clinical trials. The clinical trial market environment is becoming more and more complex. When working with Komtur Pharmaceuticals as an independent procurement partner, our customers can be assured that they will have the confidentiality and transparency they require for their procurement.
Komtur Pharmaceuticals is a reliable partner in the procurement and distribution of drugs for clinical research. Our customers are leading manufacturers, research organisations and packaging specialists for study drugs. Our clinical sourcing services include:
In addition to the procurement of reference and study drugs, Komtur Pharmaceuticals offers research-based pharmaceutical companies and their partners the option of a downstream clinical distribution service.
Our customers can opt for procurement and distribution from a single source or can combine services from both areas, depending on the design of the trial.
As a specialist for the distribution of study products, we can carry out the clinical distribution of reference and study drugs. Our services in this area include:
Komtur Pharmaceuticals offers tailor-made distribution concepts that respond to the specific project requirements of our customers – worldwide.
Komtur Pharmaceuticals can support manufacturers when it comes to distributing approved drugs internationally. We focus on drugs that impose particularly demanding requirements on logistics to keep them available internationally.
Komtur provides tailor-made drug distribution concepts that are adjusted to customer needs and product requirements. Our international drug distribution services include:
Komtur has developed a concept that can be used to make innovative drug products available even before they receive a national marketing approval. This is our pre-marketing concept for innovative drugs.
For a successful pre-marketing concept, the drug manufacturer must have obtained a marketing approval in at least one country (usually the country in which the drug was developed). In addition, applicable laws and regulations must permit the lawful import and sale to the patient in the target markets.